Cantor Fitzgerald Weighs in on Gilead Sciences FY2026 Earnings
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Gilead Sciences in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will earn $9.39 per share for the year. Cantor […]
Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) – Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for shares of Gilead Sciences in a research report issued to clients and investors on Monday, June 9th. Cantor Fitzgerald analyst C. Gould anticipates that the biopharmaceutical company will earn $9.39 per share for the year. Cantor […]
